Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1998-3-10
|
pubmed:abstractText |
To determine the efficacy and tolerability of an enteric-coated peppermint-oil formulation (Colpermin), we conducted a prospective, randomized, double-blind, placebo-controlled clinical study in 110 outpatients (66 men/44 women; 18-70 years of age) with symptoms of irritable bowel syndrome. Patients took one capsule (Colpermin or placebo) three to four times daily, 15-30 min before meals, for 1 month. Fifty-two patients on Colpermin and 49 on placebo completed the study. Forty-one patients on Colpermin (79%) experienced an alleviation of the severity of abdominal pain (29 were pain-free); 43 (83%) had less abdominal distension, 43 (83%) had reduced stool frequency, 38 (73%) had fewer borborygmi, and 41 (79%) less flatulence. Corresponding figures for the placebo group were: 21 patients (43%) with reduced pain (4 were pain-free), 14 (29%) with reduced distension, 16 (32%) with reduced stool frequency, 15 (31%) with fewer borborygmi, and 11 (22%) with less flatulence. Symptom improvements after Colpermin were significantly better than after placebo (P < 0.05; Mann-Whitney U-test). One patient on Colpermin experienced heartburn (because of chewing the capsules) and one developed a mild transient skin rash. There were no significant changes in liver function test results. Thus, in this trial, Colpermin was effective and well tolerated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0944-1174
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
765-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9430014-Adolescent,
pubmed-meshheading:9430014-Adult,
pubmed-meshheading:9430014-Aged,
pubmed-meshheading:9430014-Colonic Diseases, Functional,
pubmed-meshheading:9430014-Double-Blind Method,
pubmed-meshheading:9430014-Female,
pubmed-meshheading:9430014-Humans,
pubmed-meshheading:9430014-Male,
pubmed-meshheading:9430014-Middle Aged,
pubmed-meshheading:9430014-Oils, Volatile,
pubmed-meshheading:9430014-Parasympatholytics,
pubmed-meshheading:9430014-Plant Oils,
pubmed-meshheading:9430014-Prospective Studies,
pubmed-meshheading:9430014-Treatment Outcome
|
pubmed:year |
1997
|
pubmed:articleTitle |
Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial.
|
pubmed:affiliation |
Department of Internal Medicine, Taichung Veterans General Hospital, Taiwan.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|